Delivery Order SPE2DB20D3111-SPE2DB25FA6BZ

Award Date 1/2/25
Potential Completion Date 1/3/25
Potential Value $2.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,478.35 firm-fixed-price delivery order is for the supply of 4566591290 - ENOXAPARIN 80 MG/0.8 ML SYR 0.8ML, a specialty medication. The contract award is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,659.98 firm fixed-price delivery order is for the supply of 4566556101 - ENOXAPARIN 120 MG/0.8 ML SYR 0.8ML, a specialty medication. The contract has an ultimate completion date of November 27, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distributor. The order, valued at $1,026.42, is for the supply of ENOXAPARIN 100 MG/ML SYRINGEML, a specialty pharmaceutical product, in support of military treatment programs and facilities. No set-aside designation was used for this contract. AmerisourceBergen Drug Corp...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, to provide 4,563,636,721 units of the medication Enoxaparin 60 mg/0.6 ml syringe. The contract has a completion date of February 13, 2024 and a potential value of $2,648.72. This delivery order is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, valued at up to $999,999,999.00, to supply a...
The U.S. government awarded a delivery order contract worth $1,912.40 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,560,179,444 units of the medication Enoxaparin 120 mg/0.8 ml syringe. The contract has a completion date of March 8, 2023 and is a firm fixed-price arrangement. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with the Defense Logistics...
This is a $1,135.68 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of 150 mg/mL enoxaparin syringes, with a period of performance through May 1, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and Veterans Affairs (VA) healthcare...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of enoxaparin 120 mg/0.8 ml syringes. The $1,340.31 delivery order is a firm fixed-price contract with an ultimate completion date of August 10, 2022. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026. This IDC serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,269.90 firm fixed price delivery order is for the supply of 80 mg/0.8 mL enoxaparin syringes. The award is not set aside and has an ultimate completion date of September 30, 2024. Amerisourcebergen holds a larger $999,999,999 indefinite delivery contract with DLA Troop Support Medical through December 2025 to provide a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 100 mg/mL enoxaparin syringes. The ceiling value of this firm-fixed-price contract is $1,085.28, with a completion date of September 27, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this contract as part of its role as a prime vendor for the DLA Troop Support Medical Indefinite Delivery Contract, valued up to $999,999,999 through December...
This federal contract award is for the delivery of ENOXAPARIN 40 MG/0.4 ML syringes to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract is a firm fixed price delivery order with a potential value of $1,204.92 and a completion date of January 3, 2024. Amerisourcebergen has previously received numerous federal contract awards from...
  • SPE2DB20D3111
    Indefinite Delivery Contract
  • SPE2DB20D3111-SPE2DB25FA6BZ
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,257.11, is for the delivery of 4566823671 - ENOXAPARIN 80 MG/0.8 ML SYR 0.8ML. It is a Firm Fixed Price Delivery Order contract with a period of performance through January 3, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 4/3/25, 10:20 AM